Consensus Evoke Pharma, Inc.

Equities

EVOK

US30049G2030

Delayed Nasdaq 04:30:01 2024-03-28 pm EDT 5-day change 1st Jan Change
0.61 USD +3.95% Intraday chart for Evoke Pharma, Inc. +3.39% -41.92%

Evolution of the average Target Price on Evoke Pharma, Inc.

Price target over the last 5 years

History of analyst recommendation changes

4dd94b3a94455aa2f40b50e9f8.uTZZAD9rR7fUpA3s8YzK_UU8mhwjY_yIVf7VeQDok4c._X46NFw_D_q2lmfBu_SoqwlJ2FtHW6jaMrCyFlWi19TBAyhaRlsyx5ntTA~51eea2d3ac72602df4d079955f7b1e69

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.61 USD
Average target price
7 USD
Spread / Average Target
+1,047.54%
High Price Target
7 USD
Spread / Highest target
+1,047.54%
Low Price Target
7 USD
Spread / Lowest Target
+1,047.54%

Consensus detail

Consensus revision (last 18 months)

Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings